COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?

The authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2013-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/97
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250263257317376
author I. V. Zhirov
O. A. Nikolaeva
S. N. Tereshchenko
author_facet I. V. Zhirov
O. A. Nikolaeva
S. N. Tereshchenko
author_sort I. V. Zhirov
collection DOAJ
description The authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a component of such a combination, is justified.
format Article
id doaj-art-e7217fbd56cf44ec856591a0bf63afdc
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2013-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-e7217fbd56cf44ec856591a0bf63afdc2025-08-20T03:57:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-12-01126293310.15829/1728-8800-2013-6-29-3397COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?I. V. Zhirov0O. A. Nikolaeva1S. N. Tereshchenko2A.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowA.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowA.L. Myasnikov Research Institute of Cardiology, Russian Cardiology Scientific and Clinical Complex, MoscowThe authors present the data on the potential of the combination of angiotensin-converting enzyme inhibitors and calcium channel antagonists in the treatment of hypertensive patients with chronic heart failure and preserved left ventricular ejection fraction. The informed choice of lisinopril, as a component of such a combination, is justified.https://cardiovascular.elpub.ru/jour/article/view/97angiotensin-converting enzyme inhibitorlisinoprilamlodipinechronic heart failure with preserved left ventricular systolic function
spellingShingle I. V. Zhirov
O. A. Nikolaeva
S. N. Tereshchenko
COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
Кардиоваскулярная терапия и профилактика
angiotensin-converting enzyme inhibitor
lisinopril
amlodipine
chronic heart failure with preserved left ventricular systolic function
title COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_full COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_fullStr COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_full_unstemmed COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_short COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
title_sort combination of angiotensin converting enzyme inhibitors and calcium channel blockers in hypertensive patients with heart failure and preserved systolic function is there a place for an informed choice
topic angiotensin-converting enzyme inhibitor
lisinopril
amlodipine
chronic heart failure with preserved left ventricular systolic function
url https://cardiovascular.elpub.ru/jour/article/view/97
work_keys_str_mv AT ivzhirov combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice
AT oanikolaeva combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice
AT sntereshchenko combinationofangiotensinconvertingenzymeinhibitorsandcalciumchannelblockersinhypertensivepatientswithheartfailureandpreservedsystolicfunctionisthereaplaceforaninformedchoice